Skip to content

Polaryx Therapeutics, Inc. PLYX Operating Loss Carryforwards

Operating Loss Carryforwards at other companies

MSCI logo
MSCIMSCI
$29.8M+4.9%
PepsiCo logo
PepsiCoPEP
$35.5B+4.4%
Carrier Global logo
Carrier GlobalCARR
$1.82B+68.6%
American International Group logo
American International GroupAIG
$15.61B
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$40M
Honeywell International logo
Honeywell InternationalHON
$3.23B+3.8%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$115.64M

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's operating loss carryforwards?
Polaryx Therapeutics, Inc. (PLYX) reported operating loss carryforwards of $18.7M in Q4 2025.